Continuous glucose monitoring (CGM) is an advanced way for people with diabetes to check their glucose readings in real-time and monitor trends or patterns over time. CGM devices also provide a more complete picture of your blood glucose levels by giving you early warnings of lows and highs that HbA1C and fingerstick testing alone can’t always identify.
A CGM system consists of two components: a glucose sensor and a transmitter. The glucose sensor constantly measures the level of glucose in your blood, and the transmitter automatically sends the average to your smart device every five minutes.
The result is 288 glucose readings per day, compared to just 4-6 readings in conventional fingertip blood glucose monitoring.
Guardian Connect™ is the only CGM system that helps you outsmart both highs and lows*. With Guardian Connect, you can track and store your glucose levels and activity at any time on your smart device.
Using smart technology, Guardian Connect can also predict where your glucose levels are headed and alert you 10–60 minutes before a predicted high or low.
Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns.
Important Safety Information:
a) Do not use the Guardian Connect System for pediatric patients until you have thoroughly reviewed (with your Healthcare Professional), the system alert performance in the Guardian Connect Application User Guide and the sensor accuracy performance in the Guardian Sensor (3) Performance document. Discuss with your Healthcare Professional how to best set up your Guardian Connect System alerts to reduce the risk of missing low blood glucose or high blood glucose events. b) In the pediatric clinical study (3-18 years of age), larger differences were observed between the Guardian Connect System and actual blood glucose values compared to those differences observed in the adolescent/adult clinical study (14-75 years of age), particularly at low glucose levels. c) In the pediatric clinical study, a significant percentage of low glucose events were not detected by the Guardian Connect System. Do not rely solely on the Guardian Connect System alerts to detect low glucose. d) In the pediatric clinical study, the Guardian Connect System triggered a high percentage of false low glucose and false high glucose alerts. The Guardian Connect System is not intended to make therapy adjustments: always check your capillary blood glucose before making therapy adjustments. e) In the pediatric clinical study, enabling the ‘Alert Before Low’ and ‘Alert Before High’ predicted alerts significantly reduced the percentage of missed low blood glucose and missed high blood glucose events, but also significantly increased the percentage of false low glucose and false high glucose alerts. Do not ignore alerts from your Guardian Connect System. Always follow your treatment instructions from your Healthcare Professional when responding to an alert from your Guardian Connect System.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.